Overview
Updated 14 Jul 2026
Tina Cascone, MD, PHD, is Associate Professor with Tenure at The University of Texas MD Anderson Cancer Center, Houston, TX. The public record shows 450 publications with 13,617 citations (h-index 56), centered on Lung Cancer (NSCLC/SCLC). It also documents an investigator role on 5 registered clinical trials, industry payments reported by 13 companies, 2 NIH-funded awards (2021–2025).
- Most recent indexed publication: 2026 · Journal for immunotherapy of cancer
- Top research focus: Lung Cancer (NSCLC/SCLC)
- 5 registered trials on ClinicalTrials.gov
- Open Payments reporting from 13 companies
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Drugs & moleculesacross trials, industry payments and publications
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 34 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industrytrials, payments and federal funding
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 5 registered studies on ClinicalTrials.gov. The most recent:
- Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
Sponsor: AstraZeneca
InvestigatorPhase 2RecruitingNCT05061550 - Bintrafusp Alfa Before Surgery for the Treatment of Untreated Resectable Non-small Cell Lung Cancer
Sponsor: M.D. Anderson Cancer Center
InvestigatorPhase 2TerminatedNCT04560686 - Nivolumab With or Without Ipilimumab or Chemotherapy in Treating Patients With Previously Untreated Stage I-IIIA Non-small Cell Lung Cancer
Sponsor: M.D. Anderson Cancer Center
InvestigatorPhase 2CompletedNCT03158129
Industry payments
Updated 14 Jul 2026
13 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Merck Sharp & Dohme LLCProgram year20259 payments
- E.R. Squibb & Sons, L.L.C.Program year20257 payments
- AstraZeneca UK LimitedProgram year20254 payments
NIH funding
Updated 14 Jul 2026
2 NIH research awards on record, funded 2021–2025 per NIH RePORTER. The latest:
- Dissecting the role of B lineage cells in mediating response of resectable lung cancer to neoadjuvant immune-based therapy
University of Tx Md Anderson Can Ctr
FY2025$670,358R01CA287734 - Radioimmunogenomic Habitat Phenotypes to Predict Efficacy of Neoadjuvant Immunotherapies in Non-Small Cell Lung Cancer
University of Tx Md Anderson Can Ctr
FY2025$606,797R01CA262425 - Dissecting the role of B lineage cells in mediating response of resectable lung cancer to neoadjuvant immune-based therapy
University of Tx Md Anderson Can Ctr
FY2024$670,358R01CA287734
Publications
Updated 14 Jul 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Unbiased avidity-based isolation of antigen-specific T cells.
Journal for immunotherapy of cancer
2026 - Improving neoadjuvant and perioperative therapy in non-small-cell lung cancer.
Nature reviews. Clinical oncology
2026
Contact
An office address from a public listing. This research profile has no federal registry record to draw from.
Office address
MD Anderson Cancer Center, FC9.2032, Unit 432, Houston, TX 77030
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →faculty.mdanderson.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →faculty.mdanderson.org ↗
- Ph.D.
Medical and Surgical Oncology and Clinical Immunology, University of Campania Luigi Vanvitelli, Naples, Italy
2012verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗
Editorial & leadership rolesjournal and society appointments
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗
Awards & honorshonors on the public record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗
Secondary affiliationsappointments beyond the home institution
- Regular Faculty Member
Immunology Program, UT MD Anderson Cancer Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗ - Regular Faculty Member
Cancer Biology Program, UT MD Anderson Cancer Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗ - Regular Member
MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences (Cancer Biology and Immunology graduate programs)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →gsbs.uth.edu ↗
Media & interviewspress, podcasts and appearances
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →iaslc.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →goodpods.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →facebook.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accountspublic accounts run by this person
- ResearchGate
researchgate.net/scientific-contributions/Tina-Cascone-39926965
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by otherswhere others cite or feature them
- LinkedIn
es.linkedin.com/posts/gecp_los-doctores-tina-cascone-y-william-n-activity-7271491319871516672-ClMu
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →es.linkedin.com ↗ - LinkedIn
linkedin.com/posts/society-for-immunotherapy-of-cancer-sitc_discover-more-about-2025-sitc-at-large-director-activity-7325534831524626435-CZU1
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗ - Other
sitcancer.org/membership/2025-sitc-election/cascone
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →sitcancer.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Uday Popat, MD
The University of Texas MD Anderson Cancer Center, Houston, TX
- 1,058
- publications
- 68
- h-index
- 16
- trials
Peter Pisters, MD
The University of Texas MD Anderson Cancer Center, Houston, TX
- —
- publications
- 109
- h-index
- 8
- trials